Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02197221 |
|---|---|
| Brief Title: | Bortezomib-Melphalan Conditioning Regimen vs Melphalan for Frontline Transplant Eligible Patients With Multiple Myeloma (IFM2014-02) |
| First Submitted : | July 18, 2014 |
| First Submitted that Met QC Criteria : | July 21, 2014 |
| First Posted : | July 22, 2014 (Estimate) |
| Last Update Submitted that Met QC Criteria : | May 17, 2022 |
| Last Update Posted : | May 23, 2022 |